Lupus autoimmunity altered by cellular methylation metabolism

Autoimmunity

Volumn 46, Issue 1, 2013, Pages 21-31

  Yang, Mei Ling ^a   Gee, Alaric J P ^a   Gee, Renelle J ^a   Zurita Lopez, Cecilia I ^b   Khare, Shilpi ^b   Clarke, Steven G ^b   Mamula, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD4+ T cells; Methylthioadenosine; S adenosylmethionine; SLE; Transmethylation

Indexed keywords

5' METHYLTHIOADENOSINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; S ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL METABOLISM; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; METHYLATION; MOUSE; NONHUMAN; PURIFICATION; SIGNAL TRANSDUCTION; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; METHYLATION; MICE; MICE, INBRED MRL LPR; MICE, TRANSGENIC; S-ADENOSYLMETHIONINE; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 84872184582     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.732133     Document Type: Article

References (52)

1. Renaudineau, Y., and P. Youinou. 2011. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J. Med. 60: 10-16.
2. Sunahori, K., Y. T. Juang,V, C. Kyttaris, and G. C. Tsokos. 2011. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J. Immunol. 186: 4508-4517.
3. Mowen, K. A., J. Tang, W. Zhu, et al. 2001. Arginine methylation of STAT1 modulates IFNalpha/beta-Induced transcription. Cell 104: 731-741. (Pubitemid 32241023)
4. Richard, S., M. Morel, and P. Cleroux. 2005. Arginine methylation regulates IL-2 gene expression: A role for protein arginine methyltransferase 5 (PRMT5). Biochem. J. 388: 379-386. (Pubitemid 40732967)
5. Blanchet, F., A. Cardona, F. A. Letimier, M. S. Hershfield, and O. Acuto. 2005. CD28 costimulatory signal induces protein arginine methylation in T cells. J. Exp. Med. 202: 371-377. (Pubitemid 41126954)
6. Brahms, H., J. Raymackers, A. Union, et al. 2000. The Cterminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J. Biol. Chem. 275: 17122-17129. (Pubitemid 30398957)
7. Doyle, H. A., R. J. Gee, and M. J. Mamula. 2003. A failure to repair self-proteins leads to T cell hyperproliferation and autoantibody production. J. Immunol. 171: 2840-2847. (Pubitemid 37093503)
8. Yang, M. L., H. A. Doyle, R. J. Gee, et al. 2006. Intracellular protein modification associated with altered T cell functions in autoimmunity. J. Immunol. 177: 4541-4549. (Pubitemid 44469785)
9. Pritzker, L. B., S. Joshi, J. J. Gowan, G. Harauz, and M. A. Moscarello. 2000. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39: 5374-5381. (Pubitemid 30257077)
10. Della Ragione, F., and A. E. Pegg. 1983. Effect of analogues of 50-Methylthioadenosine on cellular metabolism. Inactivation of S-Adenosylhomocysteine hydrolase by 50-Isobutylthioadenosine. Biochem. J. 210: 429-435. (Pubitemid 13124434)
11. Ferro, A. J., A. A. Vandenbark, and M. R. MacDonald. 1981. Inactivation of S-Adenosylhomocysteine hydrolase by 50-Deoxy-50-Methylthioadenosine. Biochem. Biophys. Res. Commun. 100: 523-531.
12. Fox, I. H., R. D. Palella, D. Thompson, and C. Herring. 1982. Adenosine metabolism: Modification by S-Adenosylhomocysteine and 50-Methylthioadenosine. Arch. Biochem. Biophys. 215: 302-308. (Pubitemid 13194187)
13. Peng, S. L., S. Fatenejad, and J. Craft. 1996. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-Restricted, transgenic alpha beta T cell. Separation of autoantigen-Specific and-nonspecific help. J. Immunol. 157: 5225-5230. (Pubitemid 126448937)
14. Kracker, S., and A. Radbruch. 2004. Immunoglobulin class switching: In vitro induction and analysis. Meth. Mol. Biol. 271: 149-159.
15. Savarese, T. M., G. W. Crabtree, and R. E. Parks, Jr. 1981. 50-Methylthioadenosine phosphorylase-L. Substrate activity of 50-Deoxyadenosine with the enzyme from Sarcoma 180 cells. Biochem. Pharmacol. 30: 189-199. (Pubitemid 11210730)
16. Mamula, M. J., R. J. Gee, J. I. Elliott, et al. 1999. Isoaspartyl post-Translational modification triggers autoimmune responses to self-proteins. J. Biol. Chem. 274: 22321-22327.
17. Clarke, S. G. 2006. Inhibition of mammalian protein methyltransferases by 50-Methylthioadenosine (MTA): A mechanism of action of dietary SAMe? In Protein Methyltransferases. The Enzymes. XXIV: 467- 493. Amsterdam: Academic Press
18. Li, T. W., H. Yang, H. Peng, et al. 2012. Effects of S-Adenosylmethionine and methylthioadenosine on inflammation-Induced colon cancer in mice. Carcinogenesis 33: 427-435.
19. Lakowski, T. M., and A. Frankel. 2010. Sources of S-Adenosyl-L- homocysteine background in measuring protein arginine N-Methyltransferase activity using tandem mass spectrometry. Anal. Biochem. 396: 158-160.
20. Kamatani,N., A. L. Yu, andD. A. Carson. 1982. Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo. Blood 60: 1387-1391. (Pubitemid 13211378)
21. Batova, A., H. Cottam, J. Yu, et al. 2006. EFA (9-beta- Derythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-Selective therapy of T-cell acute lymphoblastic leukemia with L-Alanosine. Blood 107: 898-903. (Pubitemid 43156285)
22. Harasawa, H., Y. Yamada, M. Kudoh, et al. 2002. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL). Leukemia 16: 1799-1807.
23. Vertongen, F., and I. Mandelbaum. 1984. Methylthioadenosine phosphorylase and purine nucleoside phosphorylase in B-chronic lymphocytic leukemia. Thymus 6: 359-364. (Pubitemid 15175851)
24. German, D. C., C. A. Bloch, and N. M. Kredich. 1983. Measurements of S-Adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells. J. Biol. Chem. 258: 10997-11003. (Pubitemid 13021264)
25. Wu, Q. L., Y. F. Fu, W. L. Zhou, et al. 2005. Inhibition of S-Adenosyl-L-homocysteine hydrolase induces immunosuppression. J. Pharmacol. Exp. Ther. 313: 705-711.
26. Fu, Y. F., J. X. Wang, Y. Zhao, et al. 2006. S-Adenosyl-Lhomocysteine hydrolase inactivation curtails ovalbumininduced immune responses. J Pharmacol. Exp. Ther. 316: 1229-1237. (Pubitemid 43345298)
27. Wolos, J. A., K. A. Frondorf, G. F. Babcock, S. A. Stripp, and T. L. Bowlin. 1993. Immunomodulation by an inhibitor of S-Adenosyl-L-homocysteine hydrolase: Inhibition of in vitro and in vivo allogeneic responses. Cell Immunol. 149: 402-408. (Pubitemid 23228549)
28. Wolos, J. A., K. A. Frondorf, G. F. Davis, et al. 1993. Selective inhibition of T cell activation by an inhibitor of S-Adenosyl-Lhomocysteine hydrolase. J. Immunol. 150: 3264-3273. (Pubitemid 23129705)
29. Lawson, B. R., T. Eleftheriadis, V. Tardif, et al. 2012. Transmethylation in immunity and autoimmunity. Clin. Immunol 143: 8-21.
30. Saso, Y., E. M. Conner, B. R. Teegarden, and C. S. Yuan. 2001. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: Suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-Induced arthritis. J. Pharmacol. Exp. Ther. 296: 106-112. (Pubitemid 32015067)
31. Lawson, B. R., Y. Manenkova, J. Ahamed, et al. 2007. Inhibition of transmethylation down-Regulates CD4 T cell activation and curtails development of autoimmunity in a model system. J. Immunol. 178: 5366-5374. (Pubitemid 46595323)
32. Wolford, R.W.,M.K. Riscoe, L. Johnson, A. J. Ferro, and J. H. Fitchen. 1984. Effect of 50-Methylthioadenosine (a naturally occurring nucleoside) on murine hematopoiesis. Exp. Hematol. 12: 867-871. (Pubitemid 15198925)
33. Moreno, B., H. Hevia, M. Santamaria, et al. 2006. Methylthioadenosine reverses brain autoimmune disease. Ann. Neurol. 60: 323-334. (Pubitemid 44520235)
34. Moreno, B., B. Fernandez-Diez, A. Di Penta, and P. Villoslada. 2010. Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis. Mult. Scler. 16: 1102-1108.
35. Law, R. E., J. B. Stimmel, M. A. Damore, et al. 1992. Lipopolysaccharide-Induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 50-Methylthioadenosine: Roles of protein isoprenylation and carboxyl methylation reactions. Mol. Cell Biol. 12: 103-111.
36. Veal, N., C. L. Hsieh, S. Xiong, et al. 2004. Inhibition of lipopolysaccharide-Stimulated TNF-Alpha promoter activity by S-Adenosylmethionine and 50-Methylthioadenosine. Am. J. Physiol. Gastrointest. Liver Physiol. 287: H352-G362. (Pubitemid 38955255)
37. Ara, A. I., M. Xia, K. Ramani, J. M. Mato, and S. C. Lu. 2008. S-Adenosylmethionine inhibits lipopolysaccharide-Induced gene expression via modulation of histone methylation. Hepatology 47: 1655-1666. (Pubitemid 351702748)
38. Berasain, C., H. Hevia, J. Fernandez-Irigoyen, et al. 2004. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Biochim. Biophys. Acta 1690: 276-284. (Pubitemid 39423623)
39. 't Hart, B. A., R. Q. Hintzen, and J. D. Laman. 2009. Multiple sclerosis-A response-To-Damage model. Trends Mol. Med. 15: 235-244.
40. Stekman, I. L., A. M. Blasini, M. Leon-ponte, et al. 1991. Enhanced CD3-Mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum. 34: 459-467.
41. Vratsanos, G. S., S. Jung, Y. M. Park, and J. Craft. 2001. CD4( ) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: A model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193: 329-337. (Pubitemid 32524516)
42. Kong, P. L., J. M. Odegard, F. Bouzahza, et al. 2003. Intrinsic T cell defects in systemic autoimmunity. Ann. NY Acad. Sci. 987: 60-67. (Pubitemid 36584007)
43. Gessl, A., and W. Waldhausl. 1998. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-Dependent diabetes mellitus of long standing. J. Clin. Endocrinol. Metab. 83: 2204-2209. (Pubitemid 28496360)
44. Portales-perez, D., R. Gonzalez-Amaro, C. Abud-Mendoza, and S. Sanchez-Armass. 1997. Abnormalities in CD69 expression, cytosolic pH and Ca2 during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 6: 48-56. (Pubitemid 27055735)
45. Hernandez-Garcia, C., B. Fernandez-Gutierrez, I. C. Morado, A. A. Banares, and J. A. Jover. 1996. The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells. Arthritis Rheum. 39: 1277-1286. (Pubitemid 26270085)
46. Crispin, J. C., V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2008. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol. 29: 110-115.
47. Akahoshi, M.,H. Nakashima, Y. Tanaka, et al. 1999. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42: 1644-1648. (Pubitemid 30263632)
48. Tucci, M., S. Stucci, S. Strippoli, and F. Silvestris. 2010. Cytokine overproduction, T-cell activation, anDdefective T-Regulatory functions promote nephritis in systemic lupus erythematosus. J. Biomed. Biotechnol. 2010: 457146.
49. Liossis, S. N., X. Z. Ding, G. J. Dennis, and G. C. Tsokos. 1998. Altered pattern of TCR/CD3-Mediated protein-Tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest. 101: 1448-1457. (Pubitemid 28166843)
50. Yi, Y., M. McNerney, and S. K. Datta. 2000. Regulatory defects in Cbl and mitogen-Activated protein kinase (extracellular signal-Related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J. Immunol. 165: 6627-6634.
51. Tomasi, M. L., I. Tomasi, K. Ramani, et al. 2012. S-Adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology 56: 982-993.
52. Yamaji, S., A. Droggiti, S. C. Lu, et al. 2011. Adenosylmethionine regulates connexins sub-Types expressed by hepatocytes. Euro. J. Cell Biol. 90: 312-322.